AOD-9604 | AOD-X
XENE BIOLABS RESEARCH SERIES
FOR RESEARCH USE ONLY
Category: Lipolytic Peptide | Half-life: 20-30 min
Mechanism
Modified hGH Frag 176-191 | FRAG-X. Tyr-hGH 177-191. Same fat-burning domain as Frag, stabilized. No GH/IGF-1 effects.
Dosing Protocol
Reconstitution: 2 mg + 1 mL BAC = 2 mg/mL. 300 mcg = 0.15 mL = 15 units.
Critical: Identical to hGH Frag 176-191 | FRAG-X. Must be fasted. Insulin blocks effect.
AOD 9604
AOD-5X | Modified GH Fragment — Lipolytic | CAS: 221231-10-3
AOD 9604 is a synthetic analogue of the C-terminal fragment of human growth hormone (hGH), specifically the amino acids
177-191 with a tyrosine added. It mimics the fat-burning properties of hGH without stimulating IGF-1 or affecting blood
glucose. Primarily activates lipolysis via beta-3 adrenergic receptors and inhibits lipogenesis.
| Parameter | Details |
|---|---|
| Dose | 300–600 mcg/day (SubQ) |
| Timing | Fasted AM or pre-workout (30–60 minutes before eating) |
| Cycle Length | 12–16 weeks |
| Reconstitution | Bacteriostatic water |
STACKING RECOMMENDATIONS
Stack with HGH Frag 176-191 for dual lipolytic coverage (different receptor mechanisms). Add Tesamorelin or CJC+IPA to
maintain endogenous GH pulsatility. Adipotide adds receptor-level adipocyte apoptosis.
NOTE: No IGF-1 elevation, glucose neutral, and no bone/organ growth. Well tolerated. Preferred for pure fat-loss phases
From Collection
5AMINO-10X
XENE BIOLABS RESEARCH SERIES
FOR RESEARCH USE ONLY
Category: Lipolytic Peptide | Half-life: 20-30 min
Mechanism
NNMT (Nicotinamide N-Methyltransferase) inhibitor. By inhibiting NNMT in adipose tissue, 5-Amino-1MQ increases intracellular NAD+ levels, activates SIRT1 and AMPK pathways, enhances energy expenditure, promotes fat cell shrinkage, and supports metabolic rate upregulation. No direct GH or IGF-1 effects.
Dosing Protocol
50–100 mg/day oral.
50 mg capsules:
- 50 mg/day = 1 capsule
- 100 mg/day = 2 capsules
Timing: Morning, with or without food.
Cycle Length: 8–12 weeks.
Critical: Daily consistency is important for optimal results. Fasting is not required. Best used alongside a calorie-controlled diet and regular exercise program to maximize metabolic and body-composition benefits.
HGH FRAG- 5X
XENE BIOLABS RESEARCH SERIES
FOR RESEARCH USE ONLY
Category: Lipolytic Peptide | Half-life: 20-30 min
Mechanism
Modified hGH Frag 176-191 | FRAG-X. Tyr-hGH 177-191. Same fat-burning domain as Frag, stabilized. No GH/IGF-1 effects.
Dosing Protocol
Reconstitution: 2 mg + 1 mL BAC = 2 mg/mL. 300 mcg = 0.15 mL = 15 units.
Critical: Identical to hGH Frag 176-191 | FRAG-X. Must be fasted. Insulin blocks effect.
TB500
XENE BIOLABS RESEARCH SERIES
FOR RESEARCH USE ONLY
Category: Lipolytic Peptide | Half-life: 20-30 min
Mechanism
Modified hGH Frag 176-191 | FRAG-X. Tyr-hGH 177-191. Same fat-burning domain as Frag, stabilized. No GH/IGF-1 effects.
Dosing Protocol
Reconstitution: 2 mg + 1 mL BAC = 2 mg/mL. 300 mcg = 0.15 mL = 15 units.
Critical: Identical to hGH Frag 176-191 | FRAG-X. Must be fasted. Insulin blocks effect.